1.上海中医药大学附属市中医医院儿科(上海 200071)
2.上海市中医药研究院中医儿科研究所(上海 200071)
吴淑艳,女,硕士,主治医师,主要从事小儿肺脾系疾病研究工作
薛征,教授,博士研究生导师;E-mail:xz@163.com
扫 描 看 全 文
吴淑艳,刘亚尊,宋辰斐,等.平喘方对哮喘小鼠HMGB1/TLR4/NF⁃κB通路及IKKs、TGF⁃β1的影响[J].上海中医药杂志,2022,56(11):78-83.
WU Shuyan,LIU Yazun,SONG Chenfei,et al.Effects of Pingchuan Recipe on HMGB1/TLR4/NF⁃κB pathway, IKKs and TGF⁃β1 in asthmatic mice[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):78-83.
吴淑艳,刘亚尊,宋辰斐,等.平喘方对哮喘小鼠HMGB1/TLR4/NF⁃κB通路及IKKs、TGF⁃β1的影响[J].上海中医药杂志,2022,56(11):78-83. DOI: 10.16305/j.1007-1334.2022.2205072.
WU Shuyan,LIU Yazun,SONG Chenfei,et al.Effects of Pingchuan Recipe on HMGB1/TLR4/NF⁃κB pathway, IKKs and TGF⁃β1 in asthmatic mice[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):78-83. DOI: 10.16305/j.1007-1334.2022.2205072.
目的,2,研究平喘方对哮喘小鼠高迁移率族蛋白B1(HMGB1)/Toll样受体4(TLR4)/核因子-κB(NF-κB)及气道重塑相关因子IκB激酶家族(IKKs)、转化生长因子-β1(TGF-β1)的影响。,方法,2,将32只雄性Balb/c小鼠随机分为空白组、模型组、地米组、平喘方组,每组8只。采用卵清白蛋白(OVA)联合氢氧化铝腹腔注射和5%OVA雾化吸入激发的方法建立哮喘模型,当日雾化结束1 h后灌胃给药14 d。各组于最后一次给药后收集小鼠血清、肺泡灌洗液(BALF)及肺组织。采用HE染色法观察小鼠肺组织病理改变,免疫组化染色法观察HMGB1、TLR4、NF-κB表达,ELISA法检测BALF及外周血中HMGB1、TLR4、TGF-β1、IKKs含量,RT-PCR检测肺组织中,HMGB1、TLR4、NF⁃κB,及,IKKs, mRNA表达,Western blot法检测肺组织中HMGB1、TLR4蛋白表达。,结果,2,与空白组比较,模型组气道重塑严重,HMGB1、TLR4及NF-κB表达明显增强,HMGB1、TLR4、TGF-β1及IKKs含量升高(,P,<,0.05),,HMGB1,、,TLR4,、,NF⁃κB,及,IKKs ,mRNA表达升高(,P,<,0.05),HMGB1、TLR4蛋白表达升高(,P,<,0.05)。与模型组比较,平喘方组气道重塑减轻,HMGB1、TLR4、TGF-β1及IKKs含量均明显降低(,P,<,0.05),,HMGB1,、,TLR4,、,NF⁃κB, 及,IKKs ,mRNA表达降低(,P,<,0.05),HMGB1、TLR4蛋白表达减少(,P,<,0.05)。,结论,2,平喘方能降低,HMGB1,、,TLR4,、,NF⁃κB,及,IKKs, mRNA表达,降低IKKs和TGF-β1分泌,减少HMGB1、TLR4蛋白表达,减轻哮喘模型小鼠肺组织炎症,改善肺组织病理改变。
Objective,2,To study the effects of Pingchuan Recipe on high mobility group protein B1/Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB), airway remodeling related factors IκB kinase family (IKKs) and transforming growth factor-β1 (TGF-β1) in asthmatic mice.,Methods,2,Thirty-two male Balb/c mice were randomly divided into 4 groups: blank group, model group, dexamethasone group, and Pingchuan Recipe group, with 8 mice in each group. The asthma model was established by intraperitoneal injection of ovalbumin (OVA) with aluminum hydroxide and aerosolized inhalation of 5% OVA. One hour after atomization on the same day, Pingchuan Recipe was administered by gavage for 14 days. Serum, bronchoalveolar lavage fluid (BALF) and lung tissues were collected from mice in each group after the last administration. HE staining was used to observe the histopathological changes in the lungs of mice. Immunohistochemical staining was used to observe the expression of HMGB1, TLR4 and NF-κB. The content of HMGB1, TLR4, TGF-β1 and IKKs in BALF and peripheral blood was determined by ELISA. The expression of HMGB1, TLR4, NF-κB and IKKs mRNA in lung tissues was detected by RT-PCR. The expression of HMGB1 and TLR4 proteins in lung tissues was detected by Western blot.,Results,2,Compared with the condition of the blank group, the model group had severe airway remodeling, increased expression of HMGB1, TLR4 and NF-κB, increased HMGB1, TLR4, TGF-β1 and IKKs secretion (,P,<,0.05), increased ,HMGB1,, ,TLR4,, ,NF⁃κB, and ,IKKs, mRNA expression (,P,<,0.05), and increased HMGB1 and TLR4 protein expression (,P,<,0.05). Compared with the condition of the model group, Pingchuan Recipe group had alleviated airway remodeling, significantly lower HMGB1, TLR4, TGF-β1 and IKKs secretion (,P,<,0.05), reduced ,HMGB1,, ,TLR4,, ,NF⁃κB, and ,IKKs, mRNA expression (,P,<,0.05), and decreased HMGB1 and TLR4 protein expression (,P,<,0.05).,Conclusion,2,Pingchuan Recipe can reduce ,HMGB1,, ,TLR4,, ,NF,-,κB ,and ,IKKs, mRNA expression, decrease IKKs and TGF-β1 secretion, lower HMGB1 and TLR4 protein expression, alleviate the inflammation of lung tissues, and improve the pathological changes of lung tissues in asthmatic model mice.
哮喘平喘方高迁移率族蛋白B1/Toll样受体4/核因子-κB气道重塑相关因子IκB激酶家族小鼠模型中药研究
asthmaPingchuan RecipeHMGB1/TLR4/NF-κBIKKsmouse modeltraditional Chinese herbal medicine research
王宁,王立军,任筱郿,等. 西安城区儿童哮喘患病特点调查研究[J]. 陕西医学杂志,2018, 47(5): 674-677.
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志,2020, 43(12): 1023-1048.
郭赟,苏维维,冬梅,等. 无锡地区儿童支气管哮喘流行病学调查及其与空气质量的相关性分析[J]. 中华实用儿科临床杂志,2021, 36(4): 271-274.
刘亚昆,杨颖,苟旭蕾,等. 北京市大兴区0~14岁小儿过敏性支气管哮喘流行病学特征及影响因素分析[J]. 河北医药,2020, 42(11): 1739-1742.
FEHRENBACH H, WAGNER C, WEGMANN M. Airway remodeling in asthma: what really matters[J]. Cell Tissue Res, 2017, 367(3): 551-569.
陈静. 血清 IL-17、IL-33 水平与哮喘患者气道重塑的相关性[J]. 医学理论与实践,2022, 35(10): 1744-1746.
徐万超,虞坚尔,薛征,等. 平喘方对哮喘模型小鼠气道平滑肌内TLR4 mRNA和蛋白及相关炎症因子水平的影响[J]. 辽宁中医杂志,2018, 45(10): 2196-2199.
刘亚尊,虞坚尔,徐万超,等. 平喘方及拆方对哮喘模型小鼠肺组织病理及TSLP与IL-6水平的影响[J]. 上海中医药大学学报,2017, 21(2): 62-65.
吴淑艳,虞坚尔,薛征. 平喘方调控HMGB1/TLR4通路对哮喘小鼠气道炎症的影响[J].湖南中医药大学学报,2021, 41(10): 1510-1516.
李仪奎. 中药药理实验方法学[M]. 2版. 上海:上海科学技术出版社,2006: 38.
孙振球,徐勇勇. 医学统计学[M]. 4版. 北京:人民卫生出版社,2018.
孙敬方. 动物实验方法学[M]. 北京:人民卫生出版社,2002: 357.
张新光,刘芳,薛征,等. 化痰祛瘀疏肝法预防性干预对哮喘小鼠NGF-TrkA信号通路的影响[J]. 世界中医药,2013, 8(6): 652-655.
蔡妩扬,蒋骏航,钱峰. HMGB1研究进展[J]. 上海医药,2019, 40(3): 60-63.
乔俊英,张艳丽,宋丽,等. 高迁移率族蛋白B1和Toll样受体4与哮喘气道炎症的关系及维生素D的作用[J]. 西安交通大学学报(医学版),2017, 38(4): 529-535.
谷惠茹,栾斌,乔俊英,等. 1,25-(OH)2D3对哮喘小鼠肺内高迁移率蛋白B1及Toll样受体4表达的影响[J]. 中国当代儿科杂志,2014, 16(3): 301-305.
贾晨虹,王建,董力,等. 糖皮质激素对哮喘患者外周血单核细胞TLR4和相关炎症因子表达的影响[J]. 实用临床医药杂志,2015, 19(23): 41-43.
QU D, LING Z, TAN X, et al. High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-κB pathway[J]. Int J Clin Exp Pathol, 2019, 12(9): 3268-3278.
MA L, LING Z, TAN X, et al. High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma[J]. J Thorac Dis, 2015, 7(10): 1732-1741.
王嘉军,骆春艳,张伟. 高迁移率族蛋白通过Toll样受体4降低天然调节性T细胞的抑制功能及其机制[J]. 基因组学与应用生物学,2017, 36(11): 4456-4463.
王盛隆,刘海鑫,董爱爱,等. “补肾益肾、养血祛瘀”法干预支气管哮喘小鼠气道炎症及气道重塑的作用机制[J]. 中国中医急症,2021, 30(8): 1365-1369.
樊英,康淑红. 抗喘利肺汤联合西药治疗小儿哮喘临床研究[J]. 陕西中医,2018, 39(11): 1602-1605.
王至婉,李建生,余学庆,等. 支气管哮喘不同时期证候演变规律的临床调查研究[J]. 北京中医药大学学报,2016, 39(2): 136-139.
乔俊英,宋丽,张艳丽,等. 哮喘小鼠HMGB1/TLR4/NF-κB信号通路及维生素D的作用[J]. 中国现代儿科杂志,2017, 19(1): 95-103.
朴艺花,王知广,姜京植,等. 蓝萼甲素通过HMGB1/TLR4/NF-κB信号通路缓解卵清蛋白诱导的哮喘小鼠气道炎症[J]. 国际药学研究杂志,2020, 47(9): 738-744.
0
浏览量
407
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构